Dr. Kuo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly Blvd
West Hollywood, CA 90048Phone+1 310-423-6000Fax+1 310-423-2356
Education & Training
- University of California (San Francisco)Fellowship, Gastroenterology, 2004 - 2007
- Massachusetts General HospitalResidency, Internal Medicine, 2001 - 2004
- University of California San Francisco School of MedicineClass of 2001
Certifications & Licensure
- CA State Medical License 2004 - 2025
- WA State Medical License 2017 - 2019
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Top Doctors Seattle Magazine, 2018
- Fellow, AASLD AASLD, 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure Start of enrollment: 2013 Feb 01
- HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network Start of enrollment: 2011 Nov 01
- To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure Start of enrollment: 2014 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 22 citationsRacial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States.Joseph C Ahn, Marie Lauzon, Michael Luu, Mazen Noureddin, Walid Ayoub
Hepatology. 2022-12-01 - 631 citationsLedipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver DiseaseMichael Charlton, Gregory T. Everson, Steven L. Flamm, Princy Kumar, Charles Landis
Gastroenterology. 2015-09-01 - 16 citationsThe novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure.Ruben Hernaez, Constantine J Karvellas, Yan Liu, Sophie-Caroline Sacleux, Saro Khemichian
Journal of Hepatology. 2023-09-01
Professional Memberships
- American Association for the Study of Liver DiseasesMember
- European Association for the Study of the LiverMember
- American Society of TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: